|
🐜
|
Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial.
22 auth.
G. Long,
U. Trefzer,
M. Davies,
R. Kefford,
P. Ascierto,
P. Chapman,
I. Puzanov,
A. Hauschild,
C. Robert,
A. Algazi,
...
L. Mortier,
H. Tawbi,
T. Wilhelm,
L. Zimmer,
Julie C. Switzky,
S. Swann,
Anne-Marie Martin,
Mary E. Guckert,
V. Goodman,
M. Streit,
J. Kirkwood,
D. Schadendorf
|
9 |
2012 |
9
🐜
|
|
🐜
|
The Price of Tumor Control: An Analysis of Rare Side Effects of Anti-CTLA-4 Therapy in Metastatic Melanoma from the Ipilimumab Network
36 auth.
C. Voskens,
S. Goldinger,
C. Loquai,
C. Robert,
K. Kaehler,
C. Berking,
T. Bergmann,
C. Bockmeyer,
T. Eigentler,
M. Fluck,
C. Garbe,
R. Gutzmer,
S. Grabbe,
A. Hauschild,
R. Hein,
...
G. Hundorfean,
Armin Justich,
U. Keller,
C. Klein,
C. Mateus,
P. Mohr,
S. Paetzold,
I. Satzger,
D. Schadendorf,
M. Schlaeppi,
G. Schuler,
B. Schuler-Thurner,
U. Trefzer,
J. Ulrich,
Julia Vaubel,
R. von Moos,
P. Weder,
T. Wilhelm,
D. Göppner,
R. Dummer,
L. Heinzerling
|
8 |
2013 |
8
🐜
|
|
🐜
|
Phase II trial (BREAK-2) of the BRAF inhibitor dabrafenib (GSK2118436) in patients with metastatic melanoma.
20 auth.
P. Ascierto,
D. Minor,
A. Ribas,
C. Lebbé,
Anne O’Hagan,
Nikita Arya,
Mary E. Guckert,
D. Schadendorf,
R. Kefford,
J. Grob,
...
O. Hamid,
R. Amaravadi,
E. Simeone,
T. Wilhelm,
Kevin B. Kim,
G. Long,
Anne-Marie Martin,
J. Mazumdar,
V. Goodman,
U. Trefzer
|
8 |
2013 |
8
🐜
|
|
🐜
|
GABAB receptor antibodies in paraneoplastic cerebellar ataxia
12 auth.
S. Jarius,
F. Steinmeyer,
A. Knobel,
K. Streitberger,
B. Hotter,
S. Horn,
...
H. Heuer,
S. Schreiber,
T. Wilhelm,
U. Trefzer,
B. Wildemann,
K. Ruprecht
|
5 |
2013 |
5
🐜
|
|
🐜
|
Differential influence of vemurafenib and dabrafenib on patients' lymphocytes despite similar clinical efficacy in melanoma.
23 auth.
B. Schilling,
W. Sondermann,
F. Zhao,
K. Griewank,
E. Livingstone,
A. Sucker,
H. Zelba,
B. Weide,
U. Trefzer,
T. Wilhelm,
...
Carmen Loquai,
Carola Berking,
Jessica C Hassel,
K. Kähler,
J. Utikal,
Jochen Utikal,
P. A. Ghazal,
Ralf Gutzmer,
S. Goldinger,
L. Zimmer,
A. Paschen,
U. Hillen,
D. Schadendorf
|
5 |
2014 |
5
🐜
|
|
🐜
|
Effects of Label Noise on Deep Learning-Based Skin Cancer Classification
24 auth.
A. Hekler,
Jakob Nikolas Kather,
E. Krieghoff-Henning,
J. Utikal,
F. Meier,
F. Gellrich,
Julius Upmeier zu Belzen,
L. French,
J. G. Schlager,
K. Ghoreschi,
...
T. Wilhelm,
H. Kutzner,
C. Berking,
M. Heppt,
S. Haferkamp,
W. Sondermann,
D. Schadendorf,
B. Schilling,
Benjamin Izar,
Roman C. Maron,
Max Schmitt,
S. Fröhling,
D. Lipka,
T. Brinker
|
5 |
2020 |
5
🐜
|
|
🐜
|
Integrating Patient Data Into Skin Cancer Classification Using Convolutional Neural Networks: Systematic Review
24 auth.
Julia Höhn,
A. Hekler,
E. Krieghoff-Henning,
Jakob Nikolas Kather,
J. Utikal,
F. Meier,
F. Gellrich,
A. Hauschild,
L. French,
J. G. Schlager,
...
K. Ghoreschi,
T. Wilhelm,
H. Kutzner,
M. Heppt,
S. Haferkamp,
W. Sondermann,
D. Schadendorf,
B. Schilling,
Roman C. Maron,
Max Schmitt,
T. Jutzi,
S. Fröhling,
D. Lipka,
T. Brinker
|
5 |
2020 |
5
🐜
|
|
🐜
|
Sorafenib and pegylated interferon-α2b in advanced metastatic melanoma: a multicenter phase II DeCOG trial.
20 auth.
F. Egberts,
R. Gutzmer,
S. Ugurel,
J. Becker,
U. Trefzer,
A. Degen,
F. Schenck,
L. Frey,
T. Wilhelm,
J. Hassel,
...
D. Schadendorf,
E. Livingstone,
C. Mauch,
C. Garbe,
C. Berking,
K. Rass,
P. Mohr,
K. Kaehler,
M. Weichenthal,
A. Hauschild
|
4 |
2011 |
4
🐜
|
|
🐜
|
Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trial
60 auth.
Jürgen C. Becker,
S. Ugurel,
U. Leiter,
F. Meier,
R. Gutzmer,
S. Haferkamp,
L. Zimmer,
E. Livingstone,
T. Eigentler,
A. Hauschild,
F. Kiecker,
Jessica C Hassel,
P. Mohr,
M. Fluck,
I. Thomas,
...
M. Garzarolli,
I. Grimmelmann,
K. Drexler,
Alexandra N Spillner,
Sebastian Eckhardt,
D. Schadendorf,
Alexander van Akkoi,
W. V. Houdt,
T. Wilhelm,
Kimberly Farmer,
C. Ulrich,
T. Gambichler,
Leonie Bluhm,
Heidemarie Schinagl,
I. Kellner,
R. Herbst,
F. Meiss,
D. Rafei-Shamsabadi,
Sabine Sell,
M. Kaatz,
Lena M. Wulfken,
M. Hartmann,
K. Kähler,
M. Ziemer,
J. Simon,
P. Terheyden,
D. Thąci,
C. Loquai,
H. Mitzel-Rink,
S. Grabbe,
H. Stege,
M. Gaiser,
J. Utikal,
Carola Berking,
L. Heinzerling,
M. Schlaak,
D. Tomsitz,
Jörg Dyballa,
Nina Magnolo,
C. Weishaupt,
M. Berneburg,
C. Garbe,
L. Flatz,
A. Gesierich,
B. Schilling
|
4 |
2023 |
4
🐜
|
|
🐜
|
Clinical characteristics and therapy response in unresectable melanoma patients stage IIIB-IIID with in-transit and satellite metastases.
31 auth.
A. Zaremba,
Manuel Philip,
J. Hassel,
V. Glutsch,
Zeno Fiocco,
C. Loquai,
D. Rafei-Shamsabadi,
R. Gutzmer,
J. Utikal,
S. Haferkamp,
L. Reinhardt,
K. Kähler,
C. Weishaupt,
A. Moreira,
K. Thoms,
...
T. Wilhelm,
C. Pföhler,
A. Roesch,
S. Ugurel,
L. Zimmer,
Nadine Stadtler,
A. Sucker,
F. Kiecker,
L. Heinzerling,
F. Meier,
F. Meiss,
M. Schlaak,
B. Schilling,
S. Horn,
D. Schadendorf,
E. Livingstone
|
4 |
2021 |
4
🐜
|
